Correlation Between Petros Pharmaceuticals and Organogenesis Holdings

Can any of the company-specific risk be diversified away by investing in both Petros Pharmaceuticals and Organogenesis Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Petros Pharmaceuticals and Organogenesis Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Petros Pharmaceuticals and Organogenesis Holdings, you can compare the effects of market volatilities on Petros Pharmaceuticals and Organogenesis Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Petros Pharmaceuticals with a short position of Organogenesis Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Petros Pharmaceuticals and Organogenesis Holdings.

Diversification Opportunities for Petros Pharmaceuticals and Organogenesis Holdings

0.56

Correlation Coefficient

Petros Pharmaceuticals  Organogenesis Holdings

Very weak diversification

The 3 months correlation between Petros and Organogenesis is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Petros Pharmaceuticals and Organogenesis Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Organogenesis Holdings and Petros Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Petros Pharmaceuticals are associated (or correlated) with Organogenesis Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Organogenesis Holdings has no effect on the direction of Petros Pharmaceuticals i.e., Petros Pharmaceuticals and Organogenesis Holdings go up and down completely randomly.

Pair Corralation between Petros Pharmaceuticals and Organogenesis Holdings

Given the investment horizon of 90 days Petros Pharmaceuticals is expected to under-perform the Organogenesis Holdings. But the stock apears to be less risky and, when comparing its historical volatility, Petros Pharmaceuticals is 1.92 times less risky than Organogenesis Holdings. The stock trades about -0.19 of its potential returns per unit of risk. The Organogenesis Holdings is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  279.00  in Organogenesis Holdings on February 17, 2024 and sell it today you would lose (0.50) from holding Organogenesis Holdings or give up 0.18% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	95.65%
Values	Daily Returns

Petros Pharmaceuticals  vs.  Organogenesis Holdings

Petros Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Petros Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in June 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Organogenesis Holdings

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Organogenesis Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Stock's technical and fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Pair Trading with Petros Pharmaceuticals and Organogenesis Holdings

The main advantage of trading using opposite Petros Pharmaceuticals and Organogenesis Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Petros Pharmaceuticals position performs unexpectedly, Organogenesis Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organogenesis Holdings will offset losses from the drop in Organogenesis Holdings' long position.

The idea behind Petros Pharmaceuticals and Organogenesis Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.